This is a demo store. No orders will be fulfilled.

首页   400-620-6333
  • 登录
  • 注册
  • 英文站
切换导航
我的购物车
搜索
高级搜索
菜单
登录
设置
྾

柔红霉素盐酸盐, DNA 抑制剂

蒽环类抗生素。DNA和RNA合成抑制剂。
4篇引用文献 COA COA
    级别和纯度:
  • ≥90%
有货

库存信息

关闭

库存信息

关闭

库存信息

关闭

库存信息

关闭
货号 (SKU) 包装规格 是否现货 价格 数量
D122335-10mg
 10mg 现货 Stock Image
D122335-50mg
 50mg 现货 Stock Image
D122335-250mg
 250mg 现货 Stock Image
D122335-1g
 1g 现货 Stock Image
大包装询价 收藏夹 比较  SDS下载  DATASHEET  质量标准
查看相关系列
ADC Cytotoxin (99) Anti-infection (2804) Antibiotic (2632) Antibody-drug Conjugate/ADC Related (549) Apoptosis (7108) Autophagy (2848) Bacterial (5911) Cell Cycle (7376) Cell Cycle/DNA Damage (2603) DNA/RNA Synthesis (362) Topoisomerase (149) 化学生物学 (1256) 四环素类 (8)
main product photo

基本描述

别名 盐酸柔红霉素 | 柔红霉素盐酸盐 | 道诺霉素盐酸盐
英文别名 DAUNORUBICIN HYDROCHLORIDE | DAUNORUBICIN HCL | Daunomycin hydrochloride | Cerubidine | Daunomycin chlorohydrate | RP-13057 Hydrochloride | Daunomycin, hydrochloride | Daunoblastina | RP 13057 hydrochloride | Rubidomycin hydrochloride | Daunomycin HCL | O
规格或纯度 ≥90%
英文名称 Daunorubicin hydrochloride
生化机理 强效抗癌剂，已证明是 DNA 和 RNA 合成的强抑制剂。性质 自发荧光的蒽环类抗生素，抗癌药。Pgp、MRP-1 和 BCRP 的底物。已利用荧光特性来测量药物外排泵活性，以及解决许多重要问题，如多种多药耐药蛋白的胞内定位和亚细胞器（高尔基体和溶酶体）在药物螯合中的作用及其在耐药表型中的含义。根据 pH 分配型机理将柔红霉素螯合进溶酶体。蒽环类抗生素。DNA和RNA合成抑制剂。降低tau mRNA水平。诱导DNA片段化和凋亡。在体内具有抗增殖和细胞毒性作用。口服具有活性
储存温度 -20°C储存,充氩
运输条件 超低温冰袋运输
作用类型 抑制剂
作用机制 DNA 抑制剂
备注 如果有可能，您尽量在使用的当天配置溶液，并在当天使用完它。但是，如果您需要预先配制储备溶液，我们建议您将溶液等份保存在-20°C的密封小瓶中。通常，它们最多可以使用一个月。在使用前和打开样品瓶之前，我们建议您让您的产品在室温下平衡至少1小时。需要更多关于溶解度，用法和处理的建议吗？请访问我们的常见问题（FAQ）页面以获取更多详细信息。
产品介绍

Daunorubicin HCl抑制DNA和RNA合成，抑制DNA合成时，Ki为0.02 μM。强效抗癌剂，已证明是 DNA 和 RNA 合成的强抑制剂。自发荧光的蒽环类抗生素，抗癌药。Pgp、MRP-1 和 BCRP 的底物。已利用荧光特性来测量药物外排泵活性，以及解?决许多重要问题，如多种多药耐药蛋白的胞内定位和亚细?胞器（高尔基体和溶酶体）在药物螯合中的作用及其在耐?药表型中的含义。根据 pH 分配型机理将柔红霉素螯合进溶酶体。DNA 和 RNA 合成的强抑制剂。A DNA intercalator which may suppress acute leukemia proliferation

Daunorubicin HCl inhibits both DNA and RNA synthesis and inhibits DNA synthesis with Ki of 0.02 μM.
A DNA intercalator which may suppress acute leukemia proliferation
纯度 ≥90%

关联靶点（人）

S100A4 Tchem 蛋白质S100-A4(Protein S100-A4) (1 活性数据)
活性类型 活性值-log(M) 作用机制 期刊 参考文献(PubMed IDs)
ESR1 Tclin Estrogen receptor alpha (17718 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
NR3C1 Tclin Glucocorticoid receptor (14987 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
AR Tclin Androgen Receptor (11781 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
VDR Tclin Vitamin D receptor (26531 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
TSHR Tclin Thyroid stimulating hormone receptor (29986 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
ACHE Tclin Acetylcholinesterase (18204 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
PPARG Tclin Peroxisome proliferator-activated receptor gamma (15191 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
TNF Tclin TNF-alpha (1897 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
THRB Tclin Thyroid hormone receptor beta-1 (7926 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
RXRA Tclin Retinoid X receptor alpha (3637 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
CXCL8 Tchem Interleukin-8 (642 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
POLB Tchem DNA polymerase beta (23632 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
AHR Tclin Aryl hydrocarbon receptor (1071 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
PLK1 Tchem Serine/threonine-protein kinase PLK1 (28605 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
NFKB1 Tclin Nuclear factor NF-kappa-B p105 subunit (1459 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
GLP1R Tclin Glucagon-like peptide 1 receptor (111429 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
PIN1 Tchem Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 (36611 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
FPR1 Tchem Formyl peptide receptor 1 (1372 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
CYP3A4 Tclin Cytochrome P450 3A4 (53859 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
TP53 Tchem Cellular tumor antigen p53 (48468 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
A204 (242 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
A498 (42825 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
CAPAN-1 (772 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
EVSA-T (142 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
HL-60 (67320 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
HT-29 (80576 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
K562 (73714 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
MCF7 (126967 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
MOLT-4 (49676 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
NHDF (1164 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
OVCAR-3 (48710 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
PC-3 (62116 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
SK-MEL-28 (48833 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
T-24 (2342 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
UCLA P-3 (10 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
HCT-116 (91556 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
HEK293 (82097 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
HMEC (560 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
WiDr (1835 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
HepG2 (196354 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
IGROV-1 (47897 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
IGR-37 cell line (15 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
LNCaP (8286 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
Lymphoblastoid cell (5959 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
M19-MEL (15326 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
HeLa (62764 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
MDA-MB-231 (73002 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
SW-620 (52400 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
FEN1 Tchem Flap endonuclease 1 (12055 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
HIF1A Tchem Hypoxia-inducible factor 1 alpha (6027 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID

关联靶点（其它种属）

Ppard Peroxisome proliferator-activated receptor delta (358 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
Mapk1 MAP kinase ERK2 (650 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
Salmonella typhimurium (15756 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
Plasmodium falciparum (966862 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
Mus musculus (284745 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
Rattus norvegicus (775804 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
CHO (4503 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
L1210 (27553 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
P388 (20296 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
M109 (194 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
Calf thymus DNA (4845 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
Salmon testes DNA (254 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
lef Anthrax lethal factor (7585 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
Npsr1 Neuropeptide S receptor (260 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
Luciferin 4-monooxygenase (66902 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
rep Replicase polyprotein 1ab (378 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
BCHE Cholinesterase (8742 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
Mapt Microtubule-associated protein tau (6 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
Nfe2l2 Nuclear factor erythroid 2-related factor 2 (214 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
Rorc Nuclear receptor ROR-gamma (89407 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
fba Putative fructose-1,6-bisphosphate aldolase (15559 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
Impa1 Inositol monophosphatase 1 (16203 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
ffp 4'-phosphopantetheinyl transferase ffp (24982 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
FTL Ferritin light chain (43324 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
NS1 Nonstructural protein 1 (33327 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
ORF 73 (309 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
rpoB Bacterial DNA-directed RNA polymerase (88 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
SARS-CoV-2 (38078 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID

作用机制

作用机制 Action Type target ID Target Name Target Type Target Organism Binding Site Name 参考文献

名称和识别符

PubChem SID 488183611
EC号 245-723-4
分子类型 小分子
IIUPAC Name (7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride
INCHI 1S/C27H29NO10.ClH/c1-10-22(30)14(28)7-17(37-10)38-16-9-27(35,11(2)29)8-13-19(16)26(34)21-20(24(13)32)23(31)12-5-4-6-15(36-3)18(12)25(21)33;/h4-6,10,14,16-17,22,30,32,34-35H,7-9,28H2,1-3H3;1H/t10-,14-,16-,17-,22+,27-;/m0./s1
InChi Key GUGHGUXZJWAIAS-QQYBVWGSSA-N
Smiles Cl.COc1cccc2C(=O)c3c(O)c4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)c4c(O)c3C(=O)c12)C(C)=O
Isomeric SMILES C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)N)O.Cl
关联CAS 20830-81-3
PubChem CID 62770
UN Number 2811
Packing Group I
分子量 563.98
Beilstein号 4229221

化学和物理性质

溶解性 Soluble in water (≥113), methanol, ethanol (≥10), and DMSO (≥72 mg/mL).
敏感性 对湿度、热，光线敏感
比旋光度 260°
熔点 167 °C
分子量 564.000 g/mol
XLogP3
氢键供体数Hydrogen Bond Donor Count 6
氢键受体数Hydrogen Bond Acceptor Count 11
可旋转键计数Rotatable Bond Count 4
精确质量Exact Mass 563.156 Da
单同位素质量Monoisotopic Mass 563.156 Da
拓扑极表面积Topological Polar Surface Area 186.000 Ų
重原子数Heavy Atom Count 39
形式电荷Formal Charge 0
复杂度Complexity 960.000
同位素原子数Isotope Atom Count 0
定义的原子立体中心计数Defined Atom Stereocenter Count 6
未定义的原子立体中心计数Undefined Atom Stereocenter Count 0
定义的键立体中心计数Defined Bond Stereocenter Count 0
未定义的键立体中心计数Undefined Bond Stereocenter Count 0
所有立体化学键的总数The total count of all stereochemical bonds 0
共价键合单元计数Covalently-Bonded Unit Count 2

安全和危险性（GHS）

象形图 GHS06,   GHS07,   GHS08
信号词 危险
危险声明

H301: 吞咽会中毒

H302: 吞食有害

H334: 吸入可能引起过敏或哮喘病症状或呼吸困难

H341: 怀疑引起遗传缺陷

H351: 怀疑引起遗传缺陷

H360: 可能损害生育力或未出生的孩子
预防措施声明

P261: 避免吸入灰尘/烟雾/气体/雾/蒸汽/喷雾

P264: 处理后要彻底洗手。

P270: 使用本产品时，请勿进食、饮水或吸烟。

P280: 戴防护手套/穿防护服/戴防护眼罩/戴防护面具。

P281: 根据需要使用个人防护设备。

P284: 如果通风不良，请佩戴呼吸防护装置。

P321: 特殊处理（请参阅此标签上的...）。

P330: 漱口

P304+P340: 如误吸入：将人转移到空气新鲜处，保持呼吸舒适体位。

P405: 密闭存放

P501: 将内容物/容器处理到。。。

P203: 使用前，获取、阅读并遵守所有安全说明。

P301+P316: 如果吞咽：立即寻求紧急医疗救助。

P301+P317: 如果被吞咽：请寻求医疗帮助。

P318: 如果暴露或担心，请就医。

P342+P316: 如果出现呼吸道症状：立即寻求急救。
WGK Germany 3
RTECS HB7878000
Class 6.1
Merck Index 2832
个人防护装备 Eyeshields, Faceshields, full-face particle respirator type N100 (US), Gloves, respirator cartridge type N100 (US), type P1 (EN143) respirator filter, type P3 (EN 143) respirator cartridges

质检证书（CoA,COO,BSE/TSE 和分析图谱)

C of A & Other Certificates(BSE/TSE, COO):
输入批号以搜索分析图谱:

通过匹配包装上的批号来查找并下载产品的 COA，每批产品都进行了严格的验证，您可放心使用！

找到12个结果

批号(Lot Number) 证书类型 货号
F2428225 分析证书 D122335
F2428226 分析证书 D122335
F2428228 分析证书 D122335
F2428227 分析证书 D122335
C2308992 分析证书 D122335
C2308993 分析证书 D122335
C2308994 分析证书 D122335
C2308995 分析证书 D122335
C2308996 分析证书 D122335
C2308997 分析证书 D122335
C2308998 分析证书 D122335
K2210228 分析证书 D122335

显示更多⌵

可替换产品

  1. 柔红霉素盐酸盐
    柔红霉素盐酸盐
    • 10mM in DMSO

    ¥458.32

此产品的引用文献

如何在您的发表作品中引用阿拉丁的产品和网站? 引用文献检索

引用文献

1. Pengcheng Shi,Jie Zha,Xutao Guo,Feili Chen,Zhiping Fan,Fen Huang,Fanyi Meng,Xiaoli Liu,Ru Feng,Bing Xu.  (2012-12-21)  Idarubicin is superior to daunorubicin in remission induction of de novo acute myeloid leukemia patients with high MDR1 expression..  Pharmacogenomics,  14  ((1)): (17-23).  [PMID:23252945]
2. Tereza Hartmanová,Vojtěch Tambor,Juraj Lenčo,Claudia A Staab-Weijnitz,Edmund Maser,Vladimír Wsól.  (2013-01-09)  S-nitrosoglutathione covalently modifies cysteine residues of human carbonyl reductase 1 and affects its activity..  Chemico-biological interactions,  202  ((1-3)): (136-145).  [PMID:23295225]
3. Mingjuan Liu,Ji Liu,Lihui Liu,Li Yu,Bing Shi,Liping Ye,Yongqing Zhang,Hu Chen.  (2013-01-09)  A case report of acute myeloid leukemia after liver transplantation..  Acta haematologica,  129  ((4)): (225-228).  [PMID:23295767]
4. Pranjal Chandra,Hui-Bog Noh,Yoon-Bo Shim.  (2013-01-09)  Cancer cell detection based on the interaction between an anticancer drug and cell membrane components..  Chemical communications (Cambridge, England),  49  ((19)): (1900-1902).  [PMID:23296144]
5. Utz Krug,Anja Koschmieder,Daniela Schwammbach,Joachim Gerss,Nicola Tidow,Björn Steffen,Gesine Bug,Christian H Brandts,Markus Schaich,Christoph Röllig,Christian Thiede,Richard Noppeney,Matthias Stelljes,Thomas Büchner,Steffen Koschmieder,Ulrich Dührsen,Hubert Serve,Gerhard Ehninger,Wolfgang E Berdel,Carsten Müller-Tidow.  (2013-01-10)  Feasibility of azacitidine added to standard chemotherapy in older patients with acute myeloid leukemia--a randomised SAL pilot study..  PloS one,  7  ((12)): (e52695-e52695).  [PMID:23300745]
6. Gertjan J L Kaspers,Martin Zimmermann,Dirk Reinhardt,Brenda E S Gibson,Rienk Y J Tamminga,Olga Aleinikova,Hortensia Armendariz,Michael Dworzak,Shau-Yin Ha,Henrik Hasle,Liisa Hovi,Alexei Maschan,Yves Bertrand,Guy G Leverger,Bassem I Razzouk,Carmelo Rizzari,Petr Smisek,Owen Smith,Batia Stark,Ursula Creutzig.  (2013-01-16)  Improved outcome in pediatric relapsed acute myeloid leukemia: results of a randomized trial on liposomal daunorubicin by the International BFM Study Group..  Journal of clinical oncology : official journal of the American Society of Clinical Oncology,  31  ((5)): (599-607).  [PMID:23319696]
7. S Park,N Chapuis,F Saint Marcoux,C Recher,T Prebet,P Chevallier,J-Y Cahn,T Leguay,P Bories,F Witz,T Lamy,P Mayeux,C Lacombe,C Demur,J Tamburini,A Merlat,R Delepine,N Vey,F Dreyfus,M C Béné,N Ifrah,D Bouscary.  (2013-01-17)  A phase Ib GOELAMS study of the mTOR inhibitor RAD001 in association with chemotherapy for AML patients in first relapse..  Leukemia,  27  ((7)): (1479-1486).  [PMID:23321953]
8. Rocky Pramanik,Xia Sheng,Brian Ichihara,Nora Heisterkamp,Steven D Mittelman.  (2013-01-22)  Adipose tissue attracts and protects acute lymphoblastic leukemia cells from chemotherapy..  Leukemia research,  37  ((5)): (503-509).  [PMID:23332453]
9. Mona Hassanein,Eshetu G Atenafu,Andre C Schuh,Karen W L Yee,Mark D Minden,Aaron D Schimmer,Vikas Gupta,Joseph M Brandwein.  (2013-01-30)  High-dose cytarabine-based consolidation shows superior results for older AML patients with intermediate risk cytogenetics in first complete remission..  Leukemia research,  37  ((5)): (556-560).  [PMID:23357460]
10. Sarah Bertoli,Emilie Bérard,Françoise Huguet,Anne Huynh,Suzanne Tavitian,François Vergez,Sophie Dobbelstein,Nicole Dastugue,Véronique Mansat-De Mas,Eric Delabesse,Eliane Duchayne,Cécile Demur,Audrey Sarry,Valérie Lauwers-Cances,Guy Laurent,Michel Attal,Christian Récher.  (2013-02-01)  Time from diagnosis to intensive chemotherapy initiation does not adversely impact the outcome of patients with acute myeloid leukemia..  Blood,  121  ((14)): (2618-2626).  [PMID:23365464]
11. Oliver Teuffel,Kurt Leibundgut,Thomas Lehrnbecher,Todd A Alonzo,Joseph Beyene,Lillian Sung.  (2013-02-13)  Anthracyclines during induction therapy in acute myeloid leukaemia: a systematic review and meta-analysis..  British journal of haematology,  161  ((2)): (192-203).  [PMID:23398482]
12. G M Marshall,L Dalla Pozza,R Sutton,A Ng,H A de Groot-Kruseman,V H van der Velden,N C Venn,H van den Berg,E S J M de Bont,R Maarten Egeler,P M Hoogerbrugge,G J L Kaspers,M B Bierings,E van der Schoot,J van Dongen,T Law,S Cross,H Mueller,V de Haas,M Haber,T Révész,F Alvaro,R Suppiah,M D Norris,R Pieters.  (2013-02-15)  High-risk childhood acute lymphoblastic leukemia in first remission treated with novel intensive chemotherapy and allogeneic transplantation..  Leukemia,  27  ((7)): (1497-1503).  [PMID:23407458]
13. Marko Kavcic,Brian T Fisher,Yimei Li,Alix E Seif,Kari Torp,Dana M Walker,Yuan-Shung Huang,Grace E Lee,Sarah K Tasian,Marijana Vujkovic,Rochelle Bagatell,Richard Aplenc.  (2013-02-26)  Induction mortality and resource utilization in children treated for acute myeloid leukemia at free-standing pediatric hospitals in the United States..  Cancer,  119  ((10)): (1916-1923).  [PMID:23436301]
14. Richard M Stone.  (2013-02-27)  Acute myeloid leukemia in first remission: to choose transplantation or not?.  Journal of clinical oncology : official journal of the American Society of Clinical Oncology,  31  ((10)): (1262-1266).  [PMID:23439752]
15. Nobuhiro Hiramoto,Yukio Kobayashi,Junko Nomoto,Dai Maruyama,Takashi Watanabe,Naobumi Tochigi,Koh Furuta,Ken Takeda,Hirokazu Chuman,Shigeki Yagyu,Hajime Hosoi,Kensei Tobinai.  (2013-03-12)  Ewing sarcoma arising after treatment of diffuse large B-cell lymphoma..  Japanese journal of clinical oncology,  43  ((4)): (417-421).  [PMID:23475435]
16. Lili Xiang,Man Li,Yan Liu,Jiangnong Cen,Zixing Chen,Xiao Zhen,Xiaobao Xie,Xiangshan Cao,Weiying Gu.  (2013-03-22)  The clinical characteristics and prognostic significance of MN1 gene and MN1-associated microRNA expression in adult patients with de novo acute myeloid leukemia..  Annals of hematology,  92  ((8)): (1063-1069).  [PMID:23515710]
17. Benjamin Doughty,Yi Rao,Samuel W Kazer,Sheldon J J Kwok,Nicholas J Turro,Kenneth B Eisenthal.  (2013-03-27)  Probing the relative orientation of molecules bound to DNA through controlled interference using second-harmonic generation..  Proceedings of the National Academy of Sciences of the United States of America,  110  ((15)): (5756-5758).  [PMID:23530200]
18. Weiwei Jiang,Bin Li,Xinchuan Zheng,Xin Liu,Xichun Pan,Rongxin Qing,Yanyan Cen,Jiang Zheng,Hong Zhou.  (2013-04-04)  Artesunate has its enhancement on antibacterial activity of β-lactams via increasing the antibiotic accumulation within methicillin-resistant Staphylococcus aureus (MRSA)..  The Journal of antibiotics,  66  ((6)): (339-345).  [PMID:23549351]
19. Sang Min Lee,Won Sik Lee,Ho Jin Shin,Je-Jung Lee,Sang Kyun Sohn,Joon Ho Moon,Hyeon Seok Eom,Jong Ho Won,Kyoo-Hyung Lee,Je-Hwan Lee,Dae-Young Kim,Sung-Soo Yoon,Inho Kim,Chul Won Jung,Seok Jin Kim,Hawk Kim,Jae Hoon Lee,Hun-Mo Ryoo,Gyeong-Won Lee,Sung-Hyun Kim,Yeung-Chul Mun,Min Kyoung Kim,Young Don Joo.  (2013-04-06)  Escalated daunorubicin dosing as an induction treatment for Philadelphia-negative adult acute lymphoblastic leukemia..  Annals of hematology,  92  ((8)): (1101-1110).  [PMID:23558905]
20. Ursula Creutzig,Martin Zimmermann,Jean-Pierre Bourquin,Michael N Dworzak,Gudrun Fleischhack,Norbert Graf,Thomas Klingebiel,Bernhard Kremens,Thomas Lehrnbecher,Christine von Neuhoff,Jörg Ritter,Annette Sander,André Schrauder,Arend von Stackelberg,Jan Starý,Dirk Reinhardt.  (2013-05-25)  Randomized trial comparing liposomal daunorubicin with idarubicin as induction for pediatric acute myeloid leukemia: results from Study AML-BFM 2004..  Blood,  122  ((1)): (37-43).  [PMID:23704089]
21. Abhi Das,Gopinatha Suresh Kumar.  (2013-06-19)  Binding of the plant alkaloid aristololactam-β-d-glucoside and antitumor antibiotic daunomycin to single stranded polyribonucleotides..  Biochimica et biophysica acta,  1830  ((10)): (4708-4718).  [PMID:23769768]
22. Eduard Jirkovský,Olga Lenčová-Popelová,Miloš Hroch,Michaela Adamcová,Yvona Mazurová,Jaroslava Vávrová,Stanislav Mičuda,Tomáš Šimůnek,Vladimír Geršl,Martin Štěrba.  (2013-07-09)  Early and delayed cardioprotective intervention with dexrazoxane each show different potential for prevention of chronic anthracycline cardiotoxicity in rabbits..  Toxicology,  311  ((3)): (191-204).  [PMID:23831762]
23. Cedric Dos Santos,Tinisha McDonald,Yin Wei Ho,Hongjun Liu,Allen Lin,Stephen J Forman,Ya-Huei Kuo,Ravi Bhatia.  (2013-07-31)  The Src and c-Kit kinase inhibitor dasatinib enhances p53-mediated targeting of human acute myeloid leukemia stem cells by chemotherapeutic agents..  Blood,  122  ((11)): (1900-1913).  [PMID:23896410]
24. S Singh-Rambiritch,N H Wood.  (2013-08-21)  Post-chemotherapeutic resolution of acute myeloid leukaemia-induced gingival enlargement: a case report..  SADJ : journal of the South African Dental Association = tydskrif van die Suid-Afrikaanse Tandheelkundige Vereniging,  67  ((7)): (344-347).  [PMID:23951790]
25. Hiroaki Shimizu,Takayuki Saitoh,Nahoko Hatsumi,Satoru Takada,Hiroshi Handa,Takahiro Jimbo,Toru Sakura,Shuichi Miyawaki,Yoshihisa Nojima.  (2013-09-24)  Prevalence of extramedullary relapses is higher after allogeneic stem cell transplantation than after chemotherapy in adult patients with acute myeloid leukemia..  Leukemia research,  37  ((11)): (1477-1481).  [PMID:24054717]
26. Marta Stojak,Lidia Mazur,Malgorzata Opydo-Chanek,Malgorzata Lukawska,Irena Oszczapowicz.  (2013-10-15)  In vitro induction of apoptosis and necrosis by new derivatives of daunorubicin..  Anticancer research,  33  ((10)): (4439-4443).  [PMID:24123013]
27. Haisheng Peng,Dan Du,Jinqiu Zhang.  (2013-12-07)  Liposomes modified with p-aminophenyl-α-D-mannopyranoside: a promising delivery system in targeting the brain..  Therapeutic delivery,  4  ((12)): (1475-1477).  [PMID:24304243]
28. Yi-Yang Chen,Cih-En Huang,Hui-Ju Chou,Pei-Shan Tsai,Chang-Hsien Lu,Miao-Fen Chen,Kuan-Der Lee,Ping-Tsung Chen,Jrhau Lung,Chih-Cheng Chen.  (2013-12-18)  Mutant DNMT3A clone evading chemotherapy and infiltrating central nervous system in a patient with molecularly good-risk acute myeloid leukemia..  Annals of hematology,  93  ((8)): (1441-1442).  [PMID:24337413]
29. Sarah A Buckley,Megan Othus,Vladimir Vainstein,Janis L Abkowitz,Elihu H Estey,Roland B Walter.  (2014-01-03)  Prediction of adverse events during intensive induction chemotherapy for acute myeloid leukemia or high-grade myelodysplastic syndromes..  American journal of hematology,  89  ((4)): (423-428).  [PMID:24382796]
30. Steven E Coutre,Megan Othus,Bayard Powell,Cheryl L Willman,Wendy Stock,Elisabeth Paietta,Denise Levitan,Meir Wetzler,Eyal C Attar,Jessica K Altman,Steven D Gore,Tracy Maher,Kenneth J Kopecky,Martin S Tallman,Richard A Larson,Frederick R Appelbaum.  (2014-02-18)  Arsenic trioxide during consolidation for patients with previously untreated low/intermediate risk acute promyelocytic leukaemia may eliminate the need for maintenance therapy..  British journal of haematology,  165  ((4)): (497-503).  [PMID:24528179]
31. Yanyan Mei,Chao Gao,Kailing Wang,Lei Cui,Weijing Li,Xiaoxi Zhao,Feifei Liu,Minyuan Wu,Guoren Deng,Wei Ding,Hongti Jia,Zhigang Li.  (2014-04-12)  Effect of microRNA-210 on prognosis and response to chemotherapeutic drugs in pediatric acute lymphoblastic leukemia..  Cancer science,  105  ((4)): (463-472).  [PMID:24720529]
32. Jakub Hofman,Beata Malcekova,Adam Skarka,Eva Novotna,Vladimir Wsol.  (2014-05-17)  Anthracycline resistance mediated by reductive metabolism in cancer cells: the role of aldo-keto reductase 1C3..  Toxicology and applied pharmacology,  278  ((3)): (238-248).  [PMID:24832494]
33. Jessica L Heath,Shelly E Burgett,Ana M Gaca,Ronald Jaffe,Daniel S Wechsler.  (2014-06-04)  Successful treatment of pediatric histiocytic sarcoma using abbreviated high-risk leukemia chemotherapy..  Pediatric blood & cancer,  61  ((10)): (1874-1876).  [PMID:24888336]
34. Petr Kosztyu,Romana Bukvova,Petr Dolezel,Petr Mlejnek.  (2014-06-24)  Resistance to daunorubicin, imatinib, or nilotinib depends on expression levels of ABCB1 and ABCG2 in human leukemia cells..  Chemico-biological interactions,  219  (203-210).  [PMID:24954033]
35. Caroline Damico Candido,Michel Leandro Campos,Juliana Uruguay Correa Vidigal Assumpção,Kelly Chrystina Pestana,Elias Carvalho Padilha,Iracilda Zeppone Carlos,Rosângela Gonçalves Peccinini.  (2014-08-08)  Biocompatible microemulsion modifies the tissue distribution of doxorubicin..  Journal of pharmaceutical sciences,  103  ((10)): (3297-3301).  [PMID:25100266]
36. Hernan Carol,Mannie M Y Fan,Troy O Harasym,Ingrid Boehm,Lawrence D Mayer,Peter Houghton,Malcolm A Smith,Richard B Lock.  (2014-09-10)  Efficacy of CPX-351, (cytarabine:daunorubicin) liposome injection, against acute lymphoblastic leukemia (ALL) xenograft models of the Pediatric Preclinical Testing Program..  Pediatric blood & cancer,  62  ((1)): (65-71).  [PMID:25203866]
37. Jorge E Cortes,Stuart L Goldberg,Eric J Feldman,David A Rizzeri,Donna E Hogge,Melissa Larson,Arnaud Pigneux,Christian Recher,Gary Schiller,Krzysztof Warzocha,Hagop Kantarjian,Arthur C Louie,Jonathan E Kolitz.  (2014-09-17)  Phase II, multicenter, randomized trial of CPX-351 (cytarabine:daunorubicin) liposome injection versus intensive salvage therapy in adults with first relapse AML..  Cancer,  121  ((2)): (234-242).  [PMID:25223583]
38. Takuya Suzuki,Masako Ichihara,Kenji Hyodo,Eiichi Yamamoto,Tatsuhiro Ishida,Hiroshi Kiwada,Hiroshi Kikuchi,Hiroshi Ishihara.  (2014-10-05)  Influence of dose and animal species on accelerated blood clearance of PEGylated liposomal doxorubicin..  International journal of pharmaceutics,  476  ((1-2)): (205-212).  [PMID:25280884]
39. Luca Maurillo,Francesco Buccisano,Alfonso Piciocchi,Maria Ilaria Del Principe,Chiara Sarlo,Ambra Di Veroli,Paola Panetta,Maria Irno-Consalvo,Daniela Nasso,Concetta Ditto,Marco Refrigeri,Gottardo De Angelis,Raffaella Cerretti,William Arcese,Giuseppe Sconocchia,Francesco Lo-Coco,Sergio Amadori,Adriano Venditti.  (2014-11-08)  Minimal residual disease as biomarker for optimal biologic dosing of ARA-C in patients with acute myeloid leukemia..  American journal of hematology,  90  ((2)): (125-131).  [PMID:25377359]
40. Tomasz Wojcik,Elzbieta Buczek,Katarzyna Majzner,Agnieszka Kolodziejczyk,Justyna Miszczyk,Patrycja Kaczara,Wojciech Kwiatek,Malgorzata Baranska,Marek Szymonski,Stefan Chlopicki.  (2014-12-23)  Comparative endothelial profiling of doxorubicin and daunorubicin in cultured endothelial cells..  Toxicology in vitro : an international journal published in association with BIBRA,  29  ((3)): (512-521).  [PMID:25529801]
41. Daniel C Ferguson,Qiuying Cheng,Javier G Blanco.  (2015-04-29)  Characterization of the Canine Anthracycline-Metabolizing Enzyme Carbonyl Reductase 1 (cbr1) and the Functional Isoform cbr1 V218..  Drug metabolism and disposition: the biological fate of chemicals,  43  ((7)): (922-927).  [PMID:25918240]
42. Andrea R Beyer,Lauren VieBrock,Kyle G Rodino,Daniel P Miller,Brittney K Tegels,Richard T Marconi,Jason A Carlyon.  (2015-07-15)  Orientia tsutsugamushi Strain Ikeda Ankyrin Repeat-Containing Proteins Recruit SCF1 Ubiquitin Ligase Machinery via Poxvirus-Like F-Box Motifs..  Journal of bacteriology,  197  ((19)): (3097-3109).  [PMID:26170417]
43. Siyam M Ansar,Thilak Mudalige.  (2019-12-06)  Characterization of doxorubicin liposomal formulations for size-based distribution of drug and excipients using asymmetric-flow field-flow fractionation (AF4) and liquid chromatography-mass spectrometry (LC-MS)..  International journal of pharmaceutics,  574  (118906-118906).  [PMID:31805309]
44. Cristina Morales Torres,Mary Y Wu,Sebastijan Hobor,Elanor N Wainwright,Matthew J Martin,Harshil Patel,William Grey,Eva Grönroos,Steven Howell,Joana Carvalho,Ambrosius P Snijders,Michael Bustin,Dominique Bonnet,Paul D Smith,Charles Swanton,Michael Howell,Paola Scaffidi.  (2020-04-15)  Selective inhibition of cancer cell self-renewal through a Quisinostat-histone H1.0 axis..  Nature communications,  11  ((1)): (1792-1792).  [PMID:32286289]
45. Mamta Amrute-Nayak,Gloria Pegoli,Tim Holler,Alfredo Jesus Lopez-Davila,Chiara Lanzuolo,Arnab Nayak.  (2020-12-12)  Chemotherapy triggers cachexia by deregulating synergetic function of histone-modifying enzymes..  Journal of cachexia, sarcopenia and muscle,  12  ((1)): (159-176).  [PMID:33305533]
46. Jay Chhablani,Alejandra Nieto,Huiyuan Hou,Elizabeth C Wu,William R Freeman,Michael J Sailor,Lingyun Cheng.  (2013-01-17)  Oxidized porous silicon particles covalently grafted with daunorubicin as a sustained intraocular drug delivery system..  Investigative ophthalmology & visual science,  54  ((2)): (1268-1279).  [PMID:23322571]
47. Qian Ding,Ran Gu,Jiayi Liang,Xiangzhong Zhang,Yunxian Chen.  (2013-01-22)  PI-103 sensitizes acute myeloid leukemia stem cells to daunorubicin-induced cytotoxicity..  Medical oncology (Northwood, London, England),  30  ((1)): (395-395).  [PMID:23335068]
48. Ishrat Jabeen,Penpun Wetwitayaklung,Peter Chiba,Manuel Pastor,Gerhard F Ecker.  (2013-02-13)  2D- and 3D-QSAR studies of a series of benzopyranes and benzopyrano[3,4b][1,4]-oxazines as inhibitors of the multidrug transporter P-glycoprotein..  Journal of computer-aided molecular design,  27  ((2)): (161-171).  [PMID:23400406]
49. Anna Rommer,Birgit Steinmetz,Friederike Herbst,Hubert Hackl,Petra Heffeter,Daniela Heilos,Martin Filipits,Katarina Steinleitner,Shayda Hemmati,Irene Herbacek,Ilse Schwarzinger,Katharina Hartl,Pieter Rondou,Hanno Glimm,Kadin Karakaya,Alwin Krämer,Walter Berger,Rotraud Wieser.  (2013-03-05)  EVI1 inhibits apoptosis induced by antileukemic drugs via upregulation of CDKN1A/p21/WAF in human myeloid cells..  PloS one,  8  ((2)): (e56308-e56308).  [PMID:23457546]
50. Stephen H Petersdorf,Kenneth J Kopecky,Marilyn Slovak,Cheryl Willman,Thomas Nevill,Joseph Brandwein,Richard A Larson,Harry P Erba,Patrick J Stiff,Robert K Stuart,Roland B Walter,Martin S Tallman,Leif Stenke,Frederick R Appelbaum.  (2013-04-18)  A phase 3 study of gemtuzumab ozogamicin during induction and postconsolidation therapy in younger patients with acute myeloid leukemia..  Blood,  121  ((24)): (4854-4860).  [PMID:23591789]
51. Jae-Ho Yoon,Byung-Sik Cho,Hee-Je Kim,Jung-Ho Kim,Seung-Hwan Shin,Seung-Ah Yahng,Sung-Eun Lee,Ki-Seong Eom,Yoo-Jin Kim,Seok Lee,Chang-Ki Min,Seok-Goo Cho,Dong-Wook Kim,Jong-Wook Lee,Woo-Sung Min,Chong-Won Park.  (2013-08-29)  Outcomes of elderly de novo acute myeloid leukemia treated by a risk-adapted approach based on age, comorbidity, and performance status..  American journal of hematology,  88  ((12)): (1074-1081).  [PMID:23983148]
52. Carlos E Vigil,Wei Tan,George Deeb,Sheila N Sait,Annemarie W Block,Petr Starostik,Elizabeth A Griffiths,James E Thompson,Jessica D Greene,Laurie A Ford,Eunice S Wang,Meir Wetzler.  (2013-09-10)  Phase II trial of clofarabine and daunorubicin as induction therapy for acute myeloid leukemia patients greater than or equal to 60 years of age..  Leukemia research,  37  ((11)): (1468-1471).  [PMID:24011826]
53. Robert S Nickel,Frank Keller,John Bergsagel,Todd Cooper,Marla Daves,Himalee Sabnis,Glen Lew.  (2013-12-21)  Mitoxantrone as a substitute for daunorubicin during induction in newly diagnosed lymphoblastic leukemia and lymphoma..  Pediatric blood & cancer,  61  ((5)): (810-814).  [PMID:24357218]
54. Sylvain Pilorge,Sophie Rigaudeau,Florence Rabian,Clémentine Sarkozy,Anne L Taksin,Hassan Farhat,Fathia Merabet,Stéphanie Ghez,Victoria Raggueneau,Christine Terré,Isabelle Garcia,Aline Renneville,Claude Preudhomme,Sylvie Castaigne,Philippe Rousselot.  (2014-01-01)  Fractionated gemtuzumab ozogamicin and standard dose cytarabine produced prolonged second remissions in patients over the age of 55 years with acute myeloid leukemia in late first relapse..  American journal of hematology,  89  ((4)): (399-403).  [PMID:24375467]
55. Antonio R Lucena-Araujo,Haesook T Kim,Rafael H Jacomo,Raul A Melo,Rosane Bittencourt,Ricardo Pasquini,Katia Pagnano,Evandro M Fagundes,Maria de Lourdes Chauffaille,Carlos S Chiattone,Ana Silvia Lima,Guillermo Ruiz-Argüelles,Maria Soledad Undurraga,Lem Martinez,Hau C Kwaan,Robert Gallagher,Charlotte M Niemeyer,Stanley L Schrier,Martin S Tallman,David Grimwade,Arnold Ganser,Nancy Berliner,Raul C Ribeiro,Francesco Lo-Coco,Bob Löwenberg,Miguel A Sanz,Eduardo M Rego.  (2014-07-02)  Internal tandem duplication of the FLT3 gene confers poor overall survival in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based chemotherapy: an International Consortium on Acute Promyelocytic Leukemia study..  Annals of hematology,  93  ((12)): (2001-2010).  [PMID:24981688]
56. Enrico De Astis,Marino Clavio,Anna Maria Raiola,Anna Ghiso,Fabio Guolo,Paola Minetto,Federica Galaverna,Maurizio Miglino,Carmen Di Grazia,Filippo Ballerini,Carlo Marani,Giordana Pastori,Laura Mitscheunig,Fabio Cruciani,Davide Lovera,Riccardo Varaldo,Chiara Ghiggi,Roberto Massimo Lemoli,Andrea Bacigalupo,Marco Gobbi.  (2014-07-06)  Liposomal daunorubicin, fludarabine, and cytarabine (FLAD) as bridge therapy to stem cell transplant in relapsed and refractory acute leukemia..  Annals of hematology,  93  ((12)): (2011-2018).  [PMID:24989345]
57. Jiezhou Pan, Haotian Liao, Guidong Gong, Yunxiang He, Qin Wang, Lang Qin, Yaoyao Zhang, Hirotaka Ejima, Blaise L. Tardy, Joseph J. Richardson, Jiaojiao Shang, Orlando J. Rojas, Yong Zeng, Junling Guo.  (2023)  Supramolecular nanoarchitectonics of phenolic-based nanofiller for controlled diffusion of versatile drugs in hydrogels.  JOURNAL OF CONTROLLED RELEASE,  360  (433).  [PMID:37422124] [10.1016/j.jconrel.2023.07.003]
58. Bo Fu, Can Tao, Nian Chen, Jie-Rou Lin, Ping Zhao.  (2021)  ZnO QD covalently coated, GSH/pH dual-responsive drug delivery system for chemotherapeutic/ionic synergistic therapy.  JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY,  66  (102908).  [10.1016/j.jddst.2021.102908]
59. Zhifeng Xu, Peihong Deng, Junhua Li, Li Xu, Siping Tang.  (2017)  Molecularly imprinted fluorescent probe based on FRET for selective and sensitive detection of doxorubicin.  Materials Science and Engineering B-Advanced Functional Solid-State Materials,  218  (31).  [10.1016/j.mseb.2017.02.005]
60. Shule Zhang, Dong Li, Linghong Liu, Qing Shi, Xiuli Ju.  (2024)  Extracellular vesicles derived from HuMSCs alleviate daunorubicin-induced cardiac microvascular injury via miR-186-5p/PARP9/STAT1 signal pathway.  Regenerative Therapy,  25  (320).  [PMID:38327716] [10.1016/j.reth.2024.01.011]

溶液计算器

上海阿拉丁生化科技股份有限公司
© 2016 ALADDIN-E.COM . 版权所有,未经授权禁止拷贝本站资料,如有违反,将追究法律责任

本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用。

上海工商 危险品化学品经营许可证（带存储）营业执照(三证合一)